You are here: Industry Insights > Pharmaceuticals

News List

New Leader of Pharmaceuticals BU for Novartis contractpharma
June 14, 2019
Marie-France Tschudin, an experienced Novartis leader, appointed President of Novartis Pharmaceuticals.
Xeris Pharmaceuticals Receives Notification of PDUFA Date Extension for Gvoke drugs
June 14, 2019
Xeris Pharmaceuticals Receives Notification of PDUFA Date Extension for Gvoke.
Legacy Plans for Lyophilization Boom contractpharma
May 16, 2019
Five-year expansion strategy aims to address the global growth in demand for lyophilization in vials.
Exclusive: Servier Establishes First U.S. Toehold in Boston with Immediate Focus on Oncology biospace
May 13, 2019
Less than one year after France-based Servier announced the launch of its U.S. subsidiaryServier Pharmaceuticals, the new company celebrated the grand opening of its 100-employee Boston facility that will initially focus its efforts on developing oncology
Zentiva buys Amneal subsidiary Creo Pharmaceuticals pharmaceutical-technology
April 23, 2019
Zentiva buys Amneal subsidiary Creo Pharmaceuticals.
Cannabinoid topical cream for treatment of Female Hypoactive Sexual Desire Disorder europeanpharmaceuticalreview
April 22, 2019
Pivot Pharmaceuticals Inc. is to begin human clinical trials of PVT-005, the pharmaceutical drug candidate for the treatment of HSDD…
Cosmo Pharmaceuticals Announces Submission of Remimazolam NDA to FDA drugs
April 17, 2019
Cosmo Pharmaceuticals NV informed that the Remimazolam NDA has been submitted to FDA.
Highlighting Advantages of the Whole-industry-chain Layout, Starting the New Journey of Internationalization of Pharmaceuticals en-cphi.cn
March 15, 2019
Some API enterprises have gradually shifted their R&D and production focuses to the high value-added characteristic APIs...
AGC Completes Acquisition of Spanish Synthetic Pharmaceutical Active Ingredient Manufacturer Malgrat Pharma Chemicals en-cphi.cn
March 07, 2019
AGC Inc. based in Tokyo announced on March 4 the completion of its acquisition of Spain's synthetic pharmaceutical active ingredient manufacturer, Malgrat Pharma Chemicals, S.L.U. (hereinafter referred to as MPC).
EU measures in support of generic pharmaceuticals producers europeanpharmaceuticalreview
February 22, 2019
The EU is adopting new rules which should boost the competitiveness of EU producers of generic medicines and biosimilar products…

Previous page 1 2 3 4 5 6 7 Next page